Joe Fiore is Sr. Clinical Scientist at Merck & Co., Inc. in Upper Gwynedd, PA within the Clinical Sciences & Study Management group. He supports oncology clinical trials across phase I-III for the anti-PD1 drug pembrolizumab for patients with non-small cell lung cancer and advanced melanoma. Joe earned his PharmD from the University of Pittsburgh and is a registered pharmacist in the state of New Jersey. He completed his fellowship training at the Rutgers Institute for Pharmaceutical Industry Fellowships in Piscataway, NJ.